Weaver Capital Management’s Eli Lilly LLY Stock Holding History

Weaver Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.74M	Buy	7,552 +748	+11%	+$883K	1.66%	14
2026 Q2	$6.26M	Hold	6,804	–	–	1.38%	21
2026 Q1	$6.26M	Buy	6,804 +328	+5%	+$333K	1.36%	21
2025 Q4	$6.96M	Buy	6,476 +1,023	+19%	+$978K	1.47%	17
2025 Q3	$4.16M	Buy	5,453 +1,864	+52%	+$1.39M	0.9%	31
2025 Q2	$2.8M	Buy	3,589 +104	+3%	+$80.8K	0.68%	35
2025 Q1	$2.88M	Buy	3,485 +1,143	+49%	+$951K	0.76%	32
2024 Q4	$1.81M	Buy	2,342 +580	+33%	+$480K	0.5%	53
2024 Q3	$1.56M	Sell	1,762 -18	-1%	-$16.2K	0.47%	63
2024 Q2	$1.61M	Buy	1,780 +472	+36%	+$378K	0.52%	58
2024 Q1	$1.02M	Sell	1,308 -10	-0.8%	-$7.12K	0.35%	81
2023 Q4	$768K	Buy	+1,318	New	+$769K	0.3%	83

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

Private Capital Advisors Darien, Connecticut $1.15B AUM 43.46% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return

MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return

Czech National Bank Prague, Czech Republic $18.9B AUM 36.24% 1-Year Est. Return

Weaver Capital Management's LLY Position: Q3 2026 in Review

Weaver Capital Management increased its Eli Lilly (LLY) stake by 11% in Q3 2026, buying an estimated $883K and bringing the position to 7,552 shares worth $8.74M. The position accounts for 1.66% of the portfolio, ranked #14.

Weaver Capital Management first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. 939 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Weaver Capital Management held 7,552 shares of Eli Lilly worth $8.74M as of Q3 2026.
Weaver Capital Management bought 748 Eli Lilly shares in Q3 2026, an estimated $883K.
Eli Lilly made up 1.66% of Weaver Capital Management's portfolio in Q3 2026, its #14 holding.
Weaver Capital Management first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
939 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Weaver Capital Management's 13F filing for Q3 2026, filed 15 Oct 2026.